rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-8-2
|
pubmed:abstractText |
Programmed cell death (PCD) is involved in the physiological regulation of lymphocyte turnover, as well in the antigen-driven selection of T and B cells. Here it is shown that the immunomodulator linomide (quinoline-3-carboxamide) inhibits the apoptotic decay of peripheral T lymphocytes in response to three different stimuli. First, linomide reduces the superantigen-mediated apoptosis and deletion of specific T lymphocytes of both the CD4+ and the CD8+ subsets without affecting other superantigen-triggered phenomena such as T cell expansion and anergy. Second, linomide abolishes the T lymphopenia and inhibits PCD of splenic CD4+ and CD8+ T cells induced by exogenous glucocorticoids. This effect is restricted to peripheral T lymphocytes and does not concern thymocytes. Finally, linomide abolishes the development of lymphopenia that follows infection with vaccinia virus, while reducing PCD of CD4+ and CD8+ peripheral T cells. The anti-apoptotic effect of linomide could account for its immunostimulatory properties and might be relevant to the treatment of immunodeficiencies associated with an increased apoptotic decay of T lymphocytes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Enterotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyquinolines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...,
http://linkedlifedata.com/resource/pubmed/chemical/Superantigens,
http://linkedlifedata.com/resource/pubmed/chemical/enterotoxin B, staphylococcal,
http://linkedlifedata.com/resource/pubmed/chemical/roquinimex
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-2980
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
48-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8020570-Adjuvants, Immunologic,
pubmed-meshheading:8020570-Animals,
pubmed-meshheading:8020570-Apoptosis,
pubmed-meshheading:8020570-Clonal Anergy,
pubmed-meshheading:8020570-Dexamethasone,
pubmed-meshheading:8020570-Enterotoxins,
pubmed-meshheading:8020570-Flow Cytometry,
pubmed-meshheading:8020570-Hydroxyquinolines,
pubmed-meshheading:8020570-Male,
pubmed-meshheading:8020570-Mice,
pubmed-meshheading:8020570-Mice, Inbred BALB C,
pubmed-meshheading:8020570-Mice, Nude,
pubmed-meshheading:8020570-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:8020570-Spleen,
pubmed-meshheading:8020570-Superantigens,
pubmed-meshheading:8020570-T-Lymphocyte Subsets,
pubmed-meshheading:8020570-Vaccinia
|
pubmed:year |
1994
|
pubmed:articleTitle |
Linomide inhibits programmed cell death of peripheral T cells in vivo.
|
pubmed:affiliation |
Centro Nacional de Biotecnologia (CSIC), Universidad Autónoma de Madrid.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|